Suprachoroidal Injection of Triamcinolone Acetonide Injectable Suspension for the Treatment of Macular Edema Associated With Uveitis in the United States: A Cost-Effectiveness Analysis.

MLA

Bhattacharyya, Subrata, et al. “Suprachoroidal Injection of Triamcinolone Acetonide Injectable Suspension for the Treatment of Macular Edema Associated With Uveitis in the United States: A Cost-Effectiveness Analysis.” Value in Health : The Journal of the International Society for Pharmacoeconomics and Outcomes Research, vol. 25, no. 10, Oct. 2022, pp. 1705–16. EBSCOhost, https://doi.org/10.1016/j.jval.2022.07.008.

APA

Bhattacharyya, S., Hariprasad, S. M., Albini, T. A., Dutta, S. K., John, D., Padula, W. V., Harrison, D., & Joseph, G. (2022). Suprachoroidal Injection of Triamcinolone Acetonide Injectable Suspension for the Treatment of Macular Edema Associated With Uveitis in the United States: A Cost-Effectiveness Analysis. Value in Health : The Journal of the International Society for Pharmacoeconomics and Outcomes Research, 25(10), 1705–1716. https://doi.org/10.1016/j.jval.2022.07.008

Chicago

Bhattacharyya, Subrata, Seenu M Hariprasad, Thomas A Albini, Sekhar K Dutta, Denny John, William V Padula, David Harrison, and George Joseph. 2022. “Suprachoroidal Injection of Triamcinolone Acetonide Injectable Suspension for the Treatment of Macular Edema Associated With Uveitis in the United States: A Cost-Effectiveness Analysis.” Value in Health : The Journal of the International Society for Pharmacoeconomics and Outcomes Research 25 (10): 1705–16. doi:10.1016/j.jval.2022.07.008.